CTT Pharmaceutical Holdings, Inc. (CTTH)

CTTH Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2014	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2014	Feb 28, 2014	Dec 31, 2013
Selling, General & Admin	0.15	0.25	0.04	0.66	0.01	0.02
Operating Expenses	0.15	0.25	0.04	0.66	0.01	0.02
Operating Income	-0.15	-0.25	-0.04	-0.66	-0.01	-0.02
Other Non Operating Income (Expenses)	-0	-	-	-0.01	-0	-
Pretax Income	-0.15	-0.25	-0.04	-0.67	-0.02	-0.02
Net Income	-0.15	-0.25	-0.04	-0.67	-0.02	-0.02
Net Income to Common	-0.15	-0.25	-0.04	-0.67	-0.02	-0.02
Shares Outstanding (Basic)	56	52	51	16	0	15
Shares Outstanding (Diluted)	56	52	51	16	0	15
Shares Change (YoY)	194.51%	3.70%	209.26%	6435.55%	-98.32%	5867.33%
EPS (Basic)	-0.00	-0.00	-0.00	-0.04	-0.07	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.04	-0.07	-0.00
EBITDA	-0.15	-0.24	-0.04	-	-	-
D&A For EBITDA	0.01	0.01	0.01	-	-	-
EBIT	-0.15	-0.25	-0.04	-0.66	-0.01	-0.02

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.